Hayakawa, S. et al. 2016. Efficacy of recombinant human soluble thrombomodulin for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: a single arm, non-randomized prospective clinical trial. Multidisciplinary Respiratory Medicine. 11, 1 (Nov. 2016). DOI:https://doi.org/10.4081/mrm.2016.343.